SEC Info - Cell MedX Corp. - ‘10-K’ for 5/31/22

SEC Info℠

Home

My Interests

Help

Please Sign In

Cell MedX Corp. – ‘10-K’ for 5/31/22 – ‘EX-101.LAB’

On: Friday, 4/7/23, at 3:03pm ET · For: 5/31/22 · Accession #: 1393905-23-167 · File #: 0-54500

Previous ‘10-K’: ‘10-K’ on 8/30/21 for 5/31/21 · Next & Latest: ‘10-K’ on 9/1/23 for 5/31/23 · 29 References:

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/07/23  Cell MedX Corp.                   10-K        5/31/22   90:3.6M                                   Empire Stock Transf… Inc

Annual Report — Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Cell Medx Corp. - Form 10-K SEC Filing              HTML    801K 
 2: EX-10.50    Loan Agreement and Note Payable Dated April 28,     HTML     30K 
                2022, Among Cell Medx (Canada) Corp. and Richard                 
                Jeffs                                                            
 3: EX-10.51    Loan Agreement and Note Payable Dated May 31,       HTML     30K 
                2022, Among Cell Medx (Canada) Corp. and Richard                 
                Jeffs                                                            
 4: EX-10.52    Loan Agreement and Note Payable Dated June 27,      HTML     30K 
                2022, Among Cell Medx (Canada) Corp. and Richard                 
                Jeffs                                                            
 5: EX-10.53    Loan Agreement and Note Payable Dated July 28,      HTML     30K 
                2022, Among Cell Medx (Canada) Corp. and Richard                 
                Jeffs                                                            
 6: EX-10.59    Loan Agreement Dated September 2, 2022, Among Cell  HTML     27K 
                Medx (Canada) Corp. and Richard Jeffs                            
 7: EX-10.60    Loan Agreement Dated September 6, 2022, Among Cell  HTML     28K 
                Medx (Canada) Corp. and Richard Jeffs                            
 8: EX-10.61    Loan Agreement Dated November 3, 2022, Among Cell   HTML     28K 
                Medx (Canada) Corp. and Richard Jeffs                            
 9: EX-10.62    Loan Agreement Dated November 28, 2022, Among Cell  HTML     31K 
                Medx (Canada) Corp. and Richard Jeffs                            
10: EX-10.63    Loan Agreement Dated December 30, 2022, Among Cell  HTML     28K 
                Medx (Canada) Corp. and Richard Jeffs                            
11: EX-10.64    Loan Agreement Dated January 24, 2023, Among Cell   HTML     32K 
                Medx Corp. and David Jeffs                                       
12: EX-10.65    Loan Agreement Dated January 24, 2023, Among Cell   HTML     32K 
                Medx Corp. and Amir Vahabzadeh                                   
13: EX-10.66    Loan Agreement Dated January 30, 2022, Among Cell   HTML     27K 
                Medx (Canada) Corp. and Richard Jeffs                            
14: EX-21.1     List of Significant Subsidiaries                    HTML     26K 
15: EX-31.1     Certification -- §302 - SOA'02                      HTML     29K 
16: EX-31.2     Certification -- §302 - SOA'02                      HTML     29K 
17: EX-32.1     Certification -- §906 - SOA'02                      HTML     26K 
18: EX-32.2     Certification -- §906 - SOA'02                      HTML     26K 
24: R1          Document and Entity Information                     HTML     86K 
25: R2          Consolidated Balance Sheets                         HTML    106K 
26: R3          Consolidated Balance Sheets - Parenthetical         HTML     33K 
27: R4          Consolidated Statements of Operations               HTML     99K 
28: R5          Consolidated Statement of Stockholders' Deficit     HTML     86K 
29: R6          Consolidated Statements of Cash Flows               HTML     97K 
30: R7          Organization and Nature of Operations               HTML     31K 
31: R8          Summary of Significant Accounting Policies          HTML     48K 
32: R9          Related Party Transactions Disclosure               HTML     48K 
33: R10         Notes and Advances Payable Disclosure               HTML     47K 
34: R11         Other Current Assets Disclosure                     HTML     28K 
35: R12         Equipment Disclosure                                HTML     34K 
36: R13         Revenue Disclosure                                  HTML     34K 
37: R14         Notes and Advances Payable Disclosure, Current      HTML     28K 
38: R15         Stockholders' Deficit Disclosure                    HTML     59K 
39: R16         Income Taxes Disclosure                             HTML     47K 
40: R17         Subsequent Events Disclosure                        HTML     30K 
41: R18         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Basis   HTML     28K 
                of Presentation (Policies)                                       
42: R19         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:         HTML     29K 
                Principles of Consolidation, Policy (Policies)                   
43: R20         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:         HTML     31K 
                Accounting Estimates, Policy (Policies)                          
44: R21         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:         HTML     30K 
                Foreign Currency Translations and Transactions,                  
                Policy (Policies)                                                
45: R22         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:         HTML     30K 
                Revenue Recognition, Policy (Policies)                           
46: R23         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:         HTML     30K 
                Inventory Valuation, Policy (Policies)                           
47: R24         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:         HTML     29K 
                Research and Development Costs, Policy (Policies)                
48: R25         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Income  HTML     31K 
                Taxes, Policy (Policies)                                         
49: R26         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:         HTML     34K 
                Earnings Per Share, Policy (Policies)                            
50: R27         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:         HTML     30K 
                Long-lived Assets, Policy (Policies)                             
51: R28         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:         HTML     29K 
                Equipment, Policy (Policies)                                     
52: R29         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Fair    HTML     31K 
                Value Measurements, Policy (Policies)                            
53: R30         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Stock   HTML     32K 
                Options and Other Stock-based Compensation, Policy               
                (Policies)                                                       
54: R31         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Recent  HTML     28K 
                Accounting Pronouncements (Policies)                             
55: R32         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:         HTML     33K 
                Earnings Per Share, Policy: Schedule of                          
                Antidilutive Securities Excluded from Computation                
                of Earnings Per Share (Tables)                                   
56: R33         Related Party Transactions Disclosure: Schedule of  HTML     36K 
                Amounts Due to Related Parties (Tables)                          
57: R34         Related Party Transactions Disclosure: Schedule of  HTML     36K 
                Transactions with Related Parties (Tables)                       
58: R35         Notes and Advances Payable Disclosure: Schedule of  HTML     39K 
                Loans and Advances Outstanding to Related Parties                
                (Tables)                                                         
59: R36         Equipment Disclosure: Change in book value of the   HTML     33K 
                equipment (Tables)                                               
60: R37         Revenue Disclosure: Schedule of Revenue and         HTML     34K 
                Associated Costs (Tables)                                        
61: R38         Stockholders' Deficit Disclosure: Schedule of       HTML     36K 
                Stock Option Activity (Tables)                                   
62: R39         Stockholders' Deficit Disclosure: Schedule of       HTML     31K 
                Stock Options Outstanding (Tables)                               
63: R40         Stockholders' Deficit Disclosure: Schedule of       HTML     36K 
                Warrant Activity (Tables)                                        
64: R41         Stockholders' Deficit Disclosure: Schedule of       HTML     32K 
                Warrant Details (Tables)                                         
65: R42         Income Taxes Disclosure: Schedule of Effective      HTML     37K 
                Income Tax Rate Reconciliation (Tables)                          
66: R43         Income Taxes Disclosure: Schedule of Deferred Tax   HTML     34K 
                Assets and Liabilities (Tables)                                  
67: R44         Organization and Nature of Operations (Details)     HTML     30K 
68: R45         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:         HTML     31K 
                Earnings Per Share, Policy: Schedule of                          
                Antidilutive Securities Excluded from Computation                
                of Earnings Per Share (Details)                                  
69: R46         Related Party Transactions Disclosure: Schedule of  HTML     39K 
                Amounts Due to Related Parties (Details)                         
70: R47         Related Party Transactions Disclosure: Schedule of  HTML     40K 
                Transactions with Related Parties (Details)                      
71: R48         Notes and Advances Payable Disclosure: Schedule of  HTML     39K 
                Loans and Advances Outstanding to Related Parties                
                (Details)                                                        
72: R49         Notes and Advances Payable Disclosure (Details)     HTML     65K 
73: R50         Other Current Assets Disclosure (Details)           HTML     30K 
74: R51         Equipment Disclosure: Change in book value of the   HTML     36K 
                equipment (Details)                                              
75: R52         Revenue Disclosure: Schedule of Revenue and         HTML     49K 
                Associated Costs (Details)                                       
76: R53         Notes and Advances Payable Disclosure, Current      HTML     35K 
                (Details)                                                        
77: R54         Stockholders' Deficit Disclosure (Details)          HTML     78K 
78: R55         Stockholders' Deficit Disclosure: Schedule of       HTML     41K 
                Stock Option Activity (Details)                                  
79: R56         Stockholders' Deficit Disclosure: Schedule of       HTML     31K 
                Stock Options Outstanding (Details)                              
80: R57         Stockholders' Deficit Disclosure: Schedule of       HTML     34K 
                Warrant Activity (Details)                                       
81: R58         Stockholders' Deficit Disclosure: Schedule of       HTML     33K 
                Warrant Details (Details)                                        
82: R59         Income Taxes Disclosure: Schedule of Effective      HTML     54K 
                Income Tax Rate Reconciliation (Details)                         
83: R60         Income Taxes Disclosure: Schedule of Deferred Tax   HTML     37K 
                Assets and Liabilities (Details)                                 
84: R61         Income Taxes Disclosure (Details)                   HTML     30K 
85: R62         Subsequent Events Disclosure (Details)              HTML     34K 
88: XML         IDEA XML File -- Filing Summary                      XML    153K 
86: XML         XBRL Instance -- cmxc-20220531_htm                   XML    666K 
87: EXCEL       IDEA Workbook of Financial Reports                  XLSX     98K 
19: EX-101.CAL  XBRL Calculations -- cmxc-20220531_cal               XML     69K 
20: EX-101.DEF  XBRL Definitions -- cmxc-20220531_def                XML    298K 
21: EX-101.LAB  XBRL Labels -- cmxc-20220531_lab                     XML    526K 
22: EX-101.PRE  XBRL Presentations -- cmxc-20220531_pre              XML    484K 
23: EX-101.SCH  XBRL Schema -- cmxc-20220531                         XSD    145K 
89: JSON        XBRL Instance as JSON Data -- MetaLinks              258±   387K 
90: ZIP         XBRL Zipped Folder -- 0001393905-23-000167-xbrl      Zip    222K

‘EX-101.LAB’ — XBRL Labels — cmxc-20220531_lab

This Exhibit is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:fil="http://cellmedx.com/20220531" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance">

<link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_PrivatePlacementMay252021Member" xlink:label="fil_PrivatePlacementMay252021Member"/>

<link:label xlink:type="resource" xlink:label="lab_fil_PrivatePlacementMay252021Member" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Private placement, May 25, 2021 </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_PrivatePlacementMay252021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Private placement, May 25, 2021, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_PrivatePlacementMay252021Member" xlink:to="lab_fil_PrivatePlacementMay252021Member"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_ReceivablesAssociatedWithGstCellMedxCanadaMember" xlink:label="fil_ReceivablesAssociatedWithGstCellMedxCanadaMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_ReceivablesAssociatedWithGstCellMedxCanadaMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Receivables associated with GST Cell MedX Canada </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_ReceivablesAssociatedWithGstCellMedxCanadaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Receivables associated with GST Cell MedX Canada, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_ReceivablesAssociatedWithGstCellMedxCanadaMember" xlink:to="lab_fil_ReceivablesAssociatedWithGstCellMedxCanadaMember"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_BrekTechMember" xlink:label="fil_BrekTechMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_BrekTechMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Brek Tech </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_BrekTechMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Brek Tech, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_BrekTechMember" xlink:to="lab_fil_BrekTechMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Schedule of Stock Options Outstanding </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Schedule of Loans and Advances Outstanding to Related Parties </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Non-cash financing transactions </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Cash flows used in investing activities </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Stock issued for cash, value </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_ObligationToIssueSharesMember" xlink:label="fil_ObligationToIssueSharesMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_ObligationToIssueSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Obligation to Issue Shares </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_ObligationToIssueSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Obligation to Issue Shares, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_ObligationToIssueSharesMember" xlink:to="lab_fil_ObligationToIssueSharesMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Interest </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US"> Interest </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US"> Interest expense </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Common Stock, Shares, Issued </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>

<link:label xlink:type="resource" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Small Business </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>

<link:label xlink:type="resource" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Current Reporting Status </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>

<link:label xlink:type="resource" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Document Annual Report </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Options expired price per option </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_PrepaidExpensesMember" xlink:label="fil_PrepaidExpensesMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_PrepaidExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Prepaid expenses </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_PrepaidExpensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Prepaid expenses, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_PrepaidExpensesMember" xlink:to="lab_fil_PrepaidExpensesMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Accrued interest </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Stock Options and Other Stock-based Compensation, Policy </link:label>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Accounting Estimates, Policy </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_DisclosureTextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Notes </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="lab_us-gaap_DisclosureTextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:label="us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Unrealized foreign exchange </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US"> Unrealized foreign exchange </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:to="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Translation to reporting currency </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TangibleAssetImpairmentCharges" xlink:label="us-gaap_TangibleAssetImpairmentCharges"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Impairment of inventory </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TangibleAssetImpairmentCharges" xlink:to="lab_us-gaap_TangibleAssetImpairmentCharges"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Statement [Line Items] </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Statement </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_NotesAndAdvancesDueToRelatedParties" xlink:label="fil_NotesAndAdvancesDueToRelatedParties"/>

<link:label xlink:type="resource" xlink:label="lab_fil_NotesAndAdvancesDueToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Notes and advances due to related parties </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_NotesAndAdvancesDueToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the monetary amount of Notes and advances due to related parties, as of the indicated date. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_NotesAndAdvancesDueToRelatedParties" xlink:to="lab_fil_NotesAndAdvancesDueToRelatedParties"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>

<link:label xlink:type="resource" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Auditor Firm ID </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>

<link:label xlink:type="resource" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> City Area Code </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Deferred tax asset attributable to equipment </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_NotesPayableRelatedPartiesOther" xlink:label="fil_NotesPayableRelatedPartiesOther"/>

<link:label xlink:type="resource" xlink:label="lab_fil_NotesPayableRelatedPartiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Notes payable related parties, other </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_NotesPayableRelatedPartiesOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the monetary amount of Notes payable related parties, other, as of the indicated date. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_NotesPayableRelatedPartiesOther" xlink:to="lab_fil_NotesPayableRelatedPartiesOther"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_CellMedxCanadaLoansToMrJeffsMember" xlink:label="fil_CellMedxCanadaLoansToMrJeffsMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_CellMedxCanadaLoansToMrJeffsMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Cell MedX Canada loans to Mr. Jeffs </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_CellMedxCanadaLoansToMrJeffsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Cell MedX Canada loans to Mr. Jeffs, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_CellMedxCanadaLoansToMrJeffsMember" xlink:to="lab_fil_CellMedxCanadaLoansToMrJeffsMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="us-gaap_ShortTermDebtTypeDomain"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Short-Term Debt, Type </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_ManagementFeesIncurredToADirectorAndTheFormerCeoMember" xlink:label="fil_ManagementFeesIncurredToADirectorAndTheFormerCeoMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_ManagementFeesIncurredToADirectorAndTheFormerCeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Management fees incurred to a director and the former CEO </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_ManagementFeesIncurredToADirectorAndTheFormerCeoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Management fees incurred to a director and the former CEO, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_ManagementFeesIncurredToADirectorAndTheFormerCeoMember" xlink:to="lab_fil_ManagementFeesIncurredToADirectorAndTheFormerCeoMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Recent Accounting Pronouncements </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_OtherLiabilitiesDisclosureTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Revenue Disclosure </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Due to related parties: </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:to="lab_us-gaap_IncreaseDecreaseInDueToRelatedParties"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Common Stock, Shares Authorized </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Accumulated other comprehensive loss </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Additional paid-in capital </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Total current assets </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US"> Total current assets </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>

<link:label xlink:type="resource" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Emerging Growth Company </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Net deferred income tax assets </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_OptionsExercisedMember" xlink:label="fil_OptionsExercisedMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_OptionsExercisedMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Options exercised {1} </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_OptionsExercisedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US"> Options exercised </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_OptionsExercisedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Options exercised, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_OptionsExercisedMember" xlink:to="lab_fil_OptionsExercisedMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Exercise price per share </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_WarrantsGrantedJuly3020202Member" xlink:label="fil_WarrantsGrantedJuly3020202Member"/>

<link:label xlink:type="resource" xlink:label="lab_fil_WarrantsGrantedJuly3020202Member" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Warrants granted July 30, 2020(2) </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_WarrantsGrantedJuly3020202Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Warrants granted July 30, 2020(2), during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_WarrantsGrantedJuly3020202Member" xlink:to="lab_fil_WarrantsGrantedJuly3020202Member"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Schedule of Stock Option Activity </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Equipment, Policy </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Research and Development Costs, Policy </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Income Taxes Disclosure </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Net cash flows used in operating activities </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US"> Net cash flows used in operating activities </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Inventory: </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US"> Inventory: </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Other items </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Income Statement Location [Axis] </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Total liabilities and stockholders' deficit </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US"> Total liabilities and stockholders' deficit </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_Reserves" xlink:label="fil_Reserves"/>

<link:label xlink:type="resource" xlink:label="lab_fil_Reserves" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Reserves </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_Reserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the monetary amount of Reserves, as of the indicated date. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_Reserves" xlink:to="lab_fil_Reserves"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Accrued liabilities </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Accounts payable </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Effect of foreign exchange on tax rate </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_ExerciseOfOptionsAug1320202Member" xlink:label="fil_ExerciseOfOptionsAug1320202Member"/>

<link:label xlink:type="resource" xlink:label="lab_fil_ExerciseOfOptionsAug1320202Member" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Exercise of options, Aug 13, 2020(2) </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_ExerciseOfOptionsAug1320202Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Exercise of options, Aug 13, 2020(2), during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_ExerciseOfOptionsAug1320202Member" xlink:to="lab_fil_ExerciseOfOptionsAug1320202Member"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_ForeignExchangeEquipmentGL" xlink:label="fil_ForeignExchangeEquipmentGL"/>

<link:label xlink:type="resource" xlink:label="lab_fil_ForeignExchangeEquipmentGL" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Foreign exchange gain (loss), equipment </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_ForeignExchangeEquipmentGL" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Foreign exchange gain (loss), equipment </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_ForeignExchangeEquipmentGL" xlink:to="lab_fil_ForeignExchangeEquipmentGL"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_RoyaltyIncurredToACompanyOfWhichCooIsADirectorMember" xlink:label="fil_RoyaltyIncurredToACompanyOfWhichCooIsADirectorMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_RoyaltyIncurredToACompanyOfWhichCooIsADirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Royalty incurred to a company of which COO is a director </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_RoyaltyIncurredToACompanyOfWhichCooIsADirectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Royalty incurred to a company of which COO is a director, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_RoyaltyIncurredToACompanyOfWhichCooIsADirectorMember" xlink:to="lab_fil_RoyaltyIncurredToACompanyOfWhichCooIsADirectorMember"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_DueToADirectorAndTheFormerCeoMember" xlink:label="fil_DueToADirectorAndTheFormerCeoMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_DueToADirectorAndTheFormerCeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Due to a director and the former CEO </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_DueToADirectorAndTheFormerCeoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Due to a director and the former CEO, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_DueToADirectorAndTheFormerCeoMember" xlink:to="lab_fil_DueToADirectorAndTheFormerCeoMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Related Party Transaction [Axis] </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Long-lived Assets, Policy </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Income Taxes, Policy </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Other current assets: </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US"> Other current assets: </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Shares issued on settlement of debt, shares </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Common Stock, Par or Stated Value Per Share </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>

<link:label xlink:type="resource" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Auditor Name </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="lab_dei_AuditorName"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>

<link:label xlink:type="resource" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Registrant Name </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_N3RelatedPartyLoansPayableJeffsMember" xlink:label="fil_N3RelatedPartyLoansPayableJeffsMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_N3RelatedPartyLoansPayableJeffsMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> (3) Related Party Loans Payable - Jeffs </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_N3RelatedPartyLoansPayableJeffsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the (3) Related Party Loans Payable - Jeffs, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_N3RelatedPartyLoansPayableJeffsMember" xlink:to="lab_fil_N3RelatedPartyLoansPayableJeffsMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Difference in statutory tax rate </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Asset Class </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Asset Class [Axis] </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_AdvancesFromDavidJeffsMember" xlink:label="fil_AdvancesFromDavidJeffsMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_AdvancesFromDavidJeffsMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Advances from David Jeffs </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_AdvancesFromDavidJeffsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Advances from David Jeffs, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_AdvancesFromDavidJeffsMember" xlink:to="lab_fil_AdvancesFromDavidJeffsMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Effective interest rate </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayable" xlink:label="us-gaap_LoansPayable"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_LoansPayable" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Principal outstanding </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayable" xlink:to="lab_us-gaap_LoansPayable"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_ConsultingFeesIncurredToACompanyControlledByOurCooMember" xlink:label="fil_ConsultingFeesIncurredToACompanyControlledByOurCooMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_ConsultingFeesIncurredToACompanyControlledByOurCooMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Consulting fees incurred to a company controlled by our COO </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_ConsultingFeesIncurredToACompanyControlledByOurCooMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Consulting fees incurred to a company controlled by our COO, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_ConsultingFeesIncurredToACompanyControlledByOurCooMember" xlink:to="lab_fil_ConsultingFeesIncurredToACompanyControlledByOurCooMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Principles of Consolidation, Policy </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Equipment Disclosure </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Proceeds from subscription to shares </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Comprehensive loss </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalAndContractServicesExpense" xlink:label="us-gaap_ProfessionalAndContractServicesExpense"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ProfessionalAndContractServicesExpense" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Consulting fees </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalAndContractServicesExpense" xlink:to="lab_us-gaap_ProfessionalAndContractServicesExpense"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Cost of goods sold </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> LIABILITIES AND STOCKHOLDERS' DEFICIT </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>

<link:label xlink:type="resource" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Fiscal Year End </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>

<link:label xlink:type="resource" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Registrant CIK </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Less: Valuation allowance </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US"> Less: Valuation allowance </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Losses carried forward CANADA </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Expected recovery of income taxes </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_NumberOfWarrantsExercisable" xlink:label="fil_NumberOfWarrantsExercisable"/>

<link:label xlink:type="resource" xlink:label="lab_fil_NumberOfWarrantsExercisable" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Number of warrants exercisable </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_NumberOfWarrantsExercisable" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Number of warrants exercisable </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_NumberOfWarrantsExercisable" xlink:to="lab_fil_NumberOfWarrantsExercisable"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Warrants expired </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_RoyaltyPayableForEbalanceDevicesMember" xlink:label="fil_RoyaltyPayableForEbalanceDevicesMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_RoyaltyPayableForEbalanceDevicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Royalty payable for eBalance devices </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_RoyaltyPayableForEbalanceDevicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Royalty payable for eBalance devices, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_RoyaltyPayableForEbalanceDevicesMember" xlink:to="lab_fil_RoyaltyPayableForEbalanceDevicesMember"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_SalesOfEbalanceDevicesMember" xlink:label="fil_SalesOfEbalanceDevicesMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_SalesOfEbalanceDevicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Sales of eBalance devices </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_SalesOfEbalanceDevicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Sales of eBalance devices, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_SalesOfEbalanceDevicesMember" xlink:to="lab_fil_SalesOfEbalanceDevicesMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Accrued interest payable </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_InterestPayableCurrentAndNoncurrent"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Stockholders' Deficit Disclosure </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Equity Component </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Equity Components [Axis] </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Equipment </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US"> Equipment, book value </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>

<link:label xlink:type="resource" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Local Phone Number </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>

<link:label xlink:type="resource" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Incorporation, State or Country Code </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_TextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Details </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TextBlockAbstract" xlink:to="lab_us-gaap_TextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Net operating losses which may be carried forward </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Stock options outstanding </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_WarrantsGrantedJuly3020Member" xlink:label="fil_WarrantsGrantedJuly3020Member"/>

<link:label xlink:type="resource" xlink:label="lab_fil_WarrantsGrantedJuly3020Member" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Warrants granted July 30, 2020 </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_WarrantsGrantedJuly3020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Warrants granted July 30, 2020, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_WarrantsGrantedJuly3020Member" xlink:to="lab_fil_WarrantsGrantedJuly3020Member"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease" xlink:label="us-gaap_PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Increase (decrease) in equipment </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US"> Increase (decrease) in equipment </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_ManagementFeesIncurredToTheCfoMember" xlink:label="fil_ManagementFeesIncurredToTheCfoMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_ManagementFeesIncurredToTheCfoMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Management fees incurred to the CFO </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_ManagementFeesIncurredToTheCfoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Management fees incurred to the CFO, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_ManagementFeesIncurredToTheCfoMember" xlink:to="lab_fil_ManagementFeesIncurredToTheCfoMember"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_DueToCfoMember" xlink:label="fil_DueToCfoMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_DueToCfoMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Due to CFO </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_DueToCfoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Due to CFO, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_DueToCfoMember" xlink:to="lab_fil_DueToCfoMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Inventory Valuation, Policy </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Cash, beginning </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US"> Cash, beginning </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US"> Cash, ending </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Loss on settlement of debt </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US"> Loss on settlement of debt </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Retained Earnings </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentForAmortization" xlink:label="us-gaap_AdjustmentForAmortization"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Amortization </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Cash </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="lab_us-gaap_Cash"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>

<link:label xlink:type="resource" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Public Float </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>

<link:label xlink:type="resource" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Well-known Seasoned Issuer </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>

<link:label xlink:type="resource" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Address, Postal Zip Code </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>

<link:label xlink:type="resource" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Document Period End Date </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_OptionsExpiredMember" xlink:label="fil_OptionsExpiredMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_OptionsExpiredMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Options expired </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_OptionsExpiredMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Options expired, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_OptionsExpiredMember" xlink:to="lab_fil_OptionsExpiredMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtAmount" xlink:label="us-gaap_ExtinguishmentOfDebtAmount"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Debt extinguished or converted to other </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_ManagementFeesIncurredToACeoMember" xlink:label="fil_ManagementFeesIncurredToACeoMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_ManagementFeesIncurredToACeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Management fees incurred the CEO </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_ManagementFeesIncurredToACeoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Management fees incurred the CEO, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_ManagementFeesIncurredToACeoMember" xlink:to="lab_fil_ManagementFeesIncurredToACeoMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Antidilutive Securities [Axis] </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_ScheduleOfWarrantActivityTextBlock" xlink:label="fil_ScheduleOfWarrantActivityTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_fil_ScheduleOfWarrantActivityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Schedule of Warrant Activity </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_ScheduleOfWarrantActivityTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the textual narrative disclosure of Schedule of Warrant Activity, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_ScheduleOfWarrantActivityTextBlock" xlink:to="lab_fil_ScheduleOfWarrantActivityTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Cash flows provided by financing activities </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Changes in operating assets and liabilities </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:label="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Accrued interest on notes payable </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:to="lab_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Cash flows used in operating activities </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Shares issued for services, shares </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Shares issued on exercise of warrants and options, value </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:label="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Distribution expenses </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:to="lab_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesMember" xlink:label="us-gaap_SalesMember"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Sales </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesMember" xlink:to="lab_us-gaap_SalesMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> CONSOLIDATED STATEMENTS OF OPERATIONS </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Liabilities {1} </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US"> Liabilities </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Other current assets </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> ASSETS </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>

<link:label xlink:type="resource" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Document Fiscal Period Focus </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>

<link:label xlink:type="resource" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Filer Category </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_ConsolidationOfLoans" xlink:label="fil_ConsolidationOfLoans"/>

<link:label xlink:type="resource" xlink:label="lab_fil_ConsolidationOfLoans" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Consolidation of loans </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_ConsolidationOfLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the monetary amount of Consolidation of loans, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_ConsolidationOfLoans" xlink:to="lab_fil_ConsolidationOfLoans"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Permanent differences </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_WarrantsGrantedJan2920201Member" xlink:label="fil_WarrantsGrantedJan2920201Member"/>

<link:label xlink:type="resource" xlink:label="lab_fil_WarrantsGrantedJan2920201Member" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Warrants Granted Jan 29, 2020(1) </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_WarrantsGrantedJan2920201Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Warrants Granted Jan 29, 2020(1), during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_WarrantsGrantedJan2920201Member" xlink:to="lab_fil_WarrantsGrantedJan2920201Member"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Exercise price options granted </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US"> Exercise price options granted </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_DebtConversionMay320212Member" xlink:label="fil_DebtConversionMay320212Member"/>

<link:label xlink:type="resource" xlink:label="lab_fil_DebtConversionMay320212Member" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Debt conversion, May 3, 2021(2) </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_DebtConversionMay320212Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Debt conversion, May 3, 2021(2), during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_DebtConversionMay320212Member" xlink:to="lab_fil_DebtConversionMay320212Member"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_MonthlySubscMember" xlink:label="fil_MonthlySubscMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_MonthlySubscMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Monthly subscriptions </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_MonthlySubscMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Monthly subscriptions, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_MonthlySubscMember" xlink:to="lab_fil_MonthlySubscMember"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_RelatedPartyLoansPayableMember" xlink:label="fil_RelatedPartyLoansPayableMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_RelatedPartyLoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Related party loans payable </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_RelatedPartyLoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Related party loans payable, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_RelatedPartyLoansPayableMember" xlink:to="lab_fil_RelatedPartyLoansPayableMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpensesRelatedParty" xlink:label="us-gaap_CostsAndExpensesRelatedParty"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_CostsAndExpensesRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Transactions with related parties </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesRelatedParty" xlink:to="lab_us-gaap_CostsAndExpensesRelatedParty"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Related Party Transaction </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Revenue Recognition, Policy </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Notes and Advances Payable Disclosure, Current </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Increase/(decrease) in cash </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US"> Increase/(decrease) in cash </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Acquisition of equipment </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US"> Acquisition of equipment </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> CONSOLIDATED STATEMENTS OF CASH FLOWS </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Shares issued for services, value </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Revenue </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Common stock, $0.001 par value, 300,000,000 shares authorized; 62,923,063 and 62,073,064 shares issued and outstanding at May 31, 2022 and 2021, respectively </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>

<link:label xlink:type="resource" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Amendment Flag </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>

<link:label xlink:type="resource" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Interactive Data Current </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_DebtConversionMay32021Member" xlink:label="fil_DebtConversionMay32021Member"/>

<link:label xlink:type="resource" xlink:label="lab_fil_DebtConversionMay32021Member" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Debt conversion, May 3, 2021 </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_DebtConversionMay32021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Debt conversion, May 3, 2021, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_DebtConversionMay32021Member" xlink:to="lab_fil_DebtConversionMay32021Member"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_CostOfEbalanceDevicesMember" xlink:label="fil_CostOfEbalanceDevicesMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_CostOfEbalanceDevicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Cost of eBalance devices </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_CostOfEbalanceDevicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Cost of eBalance devices, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_CostOfEbalanceDevicesMember" xlink:to="lab_fil_CostOfEbalanceDevicesMember"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_AdvancesDaCostaManagementMember" xlink:label="fil_AdvancesDaCostaManagementMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_AdvancesDaCostaManagementMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Advances, Da Costa Management </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_AdvancesDaCostaManagementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Advances, Da Costa Management, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_AdvancesDaCostaManagementMember" xlink:to="lab_fil_AdvancesDaCostaManagementMember"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_RelatedPartyLoansPayableMrsJeffsMember" xlink:label="fil_RelatedPartyLoansPayableMrsJeffsMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_RelatedPartyLoansPayableMrsJeffsMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Related Party Loans Payable - Mrs. Jeffs </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_RelatedPartyLoansPayableMrsJeffsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Related Party Loans Payable - Mrs. Jeffs, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_RelatedPartyLoansPayableMrsJeffsMember" xlink:to="lab_fil_RelatedPartyLoansPayableMrsJeffsMember"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_ConsultingFeesIncurredToTheVpOfTechnologyAndOperationsMember" xlink:label="fil_ConsultingFeesIncurredToTheVpOfTechnologyAndOperationsMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_ConsultingFeesIncurredToTheVpOfTechnologyAndOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Consulting fees incurred to the VP of Technology and Operations </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_ConsultingFeesIncurredToTheVpOfTechnologyAndOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Consulting fees incurred to the VP of Technology and Operations, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_ConsultingFeesIncurredToTheVpOfTechnologyAndOperationsMember" xlink:to="lab_fil_ConsultingFeesIncurredToTheVpOfTechnologyAndOperationsMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Net cash provided by financing activities </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US"> Net cash provided by financing activities </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Accrued liabilities: </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Common Stock </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>

<link:label xlink:type="resource" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Voluntary Filers </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>

<link:label xlink:type="resource" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Address, City or Town </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>

<link:label xlink:type="resource" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity File Number </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_LoansOtherMember" xlink:label="fil_LoansOtherMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_LoansOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Loans, other </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_LoansOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Loans, other, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_LoansOtherMember" xlink:to="lab_fil_LoansOtherMember"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_WarrantsGrantedJan2920202Member" xlink:label="fil_WarrantsGrantedJan2920202Member"/>

<link:label xlink:type="resource" xlink:label="lab_fil_WarrantsGrantedJan2920202Member" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Warrants Granted Jan 29, 2020(2) </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_WarrantsGrantedJan2920202Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Warrants Granted Jan 29, 2020(2), during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_WarrantsGrantedJan2920202Member" xlink:to="lab_fil_WarrantsGrantedJan2920202Member"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Warrants exercised </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_WarrantsIssued" xlink:label="fil_WarrantsIssued"/>

<link:label xlink:type="resource" xlink:label="lab_fil_WarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Warrants issued </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_WarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Issuance of warrants to acquire common stock </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_WarrantsIssued" xlink:to="lab_fil_WarrantsIssued"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Options outsanding, weighted average exercise price </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_ExerciseOfOptionsAug132020Member" xlink:label="fil_ExerciseOfOptionsAug132020Member"/>

<link:label xlink:type="resource" xlink:label="lab_fil_ExerciseOfOptionsAug132020Member" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Exercise of options, Aug 13, 2020 </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_ExerciseOfOptionsAug132020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Exercise of options, Aug 13, 2020, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_ExerciseOfOptionsAug132020Member" xlink:to="lab_fil_ExerciseOfOptionsAug132020Member"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Deferred Bonus and Profit Sharing Arrangements, Individual Contracts, Type of Deferred Compensation [Axis] </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_DueToACompanyOfWhichTheCooIsADirectorOfMember" xlink:label="fil_DueToACompanyOfWhichTheCooIsADirectorOfMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_DueToACompanyOfWhichTheCooIsADirectorOfMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Due to a company of which the COO is a director of </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_DueToACompanyOfWhichTheCooIsADirectorOfMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Due to a company of which the COO is a director of, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_DueToACompanyOfWhichTheCooIsADirectorOfMember" xlink:to="lab_fil_DueToACompanyOfWhichTheCooIsADirectorOfMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Antidilutive Securities </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Change in book value of the equipment </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Fair Value Measurements, Policy </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Earnings Per Share, Policy </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_PolicyTextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Policies </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="lab_us-gaap_PolicyTextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Proceeds from exercise of options for debt </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Accounts payable: </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> AOCI Attributable to Parent </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Operating expenses </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Current assets </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>

<link:label xlink:type="resource" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Common Stock, Shares Outstanding </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>

<link:label xlink:type="resource" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Document Type </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="lab_dei_DocumentType"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Change in valuation allowance </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Net loss </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Options exercised price per option </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Options exercised </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US"> Options exercised </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtPercentageBearingFixedInterestRate" xlink:label="us-gaap_ShortTermDebtPercentageBearingFixedInterestRate"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ShortTermDebtPercentageBearingFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Annual interest rate - debt </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtPercentageBearingFixedInterestRate" xlink:to="lab_us-gaap_ShortTermDebtPercentageBearingFixedInterestRate"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_LoansToDavidJeffsMember" xlink:label="fil_LoansToDavidJeffsMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_LoansToDavidJeffsMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Loans to David Jeffs </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_LoansToDavidJeffsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Loans to David Jeffs, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_LoansToDavidJeffsMember" xlink:to="lab_fil_LoansToDavidJeffsMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Short-Term Debt, Type [Axis] </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Antidilutive Securities, Name </link:label>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:label="us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Schedule of Revenue and Associated Costs </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:to="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_ScheduleOfTransactionsWithRelatedPartiesTextBlock" xlink:label="fil_ScheduleOfTransactionsWithRelatedPartiesTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_fil_ScheduleOfTransactionsWithRelatedPartiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Schedule of Transactions with Related Parties </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_ScheduleOfTransactionsWithRelatedPartiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Tabular Disclosure </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_ScheduleOfTransactionsWithRelatedPartiesTextBlock" xlink:to="lab_fil_ScheduleOfTransactionsWithRelatedPartiesTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Basis of Presentation </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Related Party Transactions Disclosure </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Effects of foreign currency exchange on cash </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Proceeds from notes payable </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="lab_us-gaap_ProceedsFromNotesPayable"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Shares issued on settlement of debt, value </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Equity Balance, Shares </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US"> Equity Balance, Shares </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US"> Equity Balance, Shares </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Total stockholders' deficit </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US"> Total stockholders' deficit </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US"> Equity Balance </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US"> Equity Balance </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Total assets </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US"> Total assets </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="lab_us-gaap_Assets"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>

<link:label xlink:type="resource" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Document Fiscal Year Focus </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>

<link:label xlink:type="resource" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Address, State or Province </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Losses carried forward US </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Stock Option shares, increase (decrease) </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ProceedsFromRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Related party payables, proceeds </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="lab_us-gaap_ProceedsFromRelatedPartyDebt"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_LoansToACompanyDavidJeffsIsADirectorOfMember" xlink:label="fil_LoansToACompanyDavidJeffsIsADirectorOfMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_LoansToACompanyDavidJeffsIsADirectorOfMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Loans to a company David Jeffs is a director of </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_LoansToACompanyDavidJeffsIsADirectorOfMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Loans to a company David Jeffs is a director of, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_LoansToACompanyDavidJeffsIsADirectorOfMember" xlink:to="lab_fil_LoansToACompanyDavidJeffsIsADirectorOfMember"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_DueToTheCeoMember" xlink:label="fil_DueToTheCeoMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_DueToTheCeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Due to the CEO </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_DueToTheCeoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Due to the CEO, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_DueToTheCeoMember" xlink:to="lab_fil_DueToTheCeoMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Schedule of Warrant Details </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_NonCashIrFees" xlink:label="fil_NonCashIrFees"/>

<link:label xlink:type="resource" xlink:label="lab_fil_NonCashIrFees" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Non-cash IR fees </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_NonCashIrFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the monetary amount of Non-cash IR fees, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_NonCashIrFees" xlink:to="lab_fil_NonCashIrFees"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>

<link:label xlink:type="resource" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Auditor Location </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>

<link:label xlink:type="resource" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Shell Company </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>

<link:label xlink:type="resource" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Tax Identification Number </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Statutory tax rate </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_RelatedPartyPayablesLoans" xlink:label="fil_RelatedPartyPayablesLoans"/>

<link:label xlink:type="resource" xlink:label="lab_fil_RelatedPartyPayablesLoans" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Related party loans </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_RelatedPartyPayablesLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the monetary amount of Related party payables, loans, as of the indicated date. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_RelatedPartyPayablesLoans" xlink:to="lab_fil_RelatedPartyPayablesLoans"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_LoanAgreementWithMrHargreavesTheCompanySDirectorAndVpOfTechnologyAndOperationsMember" xlink:label="fil_LoanAgreementWithMrHargreavesTheCompanySDirectorAndVpOfTechnologyAndOperationsMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_LoanAgreementWithMrHargreavesTheCompanySDirectorAndVpOfTechnologyAndOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> loan agreement with Mr. Hargreaves, the Company's director and VP of Technology and Operations </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_LoanAgreementWithMrHargreavesTheCompanySDirectorAndVpOfTechnologyAndOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the loan agreement with Mr. Hargreaves, the Company's director and VP of Technology and Operations, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_LoanAgreementWithMrHargreavesTheCompanySDirectorAndVpOfTechnologyAndOperationsMember" xlink:to="lab_fil_LoanAgreementWithMrHargreavesTheCompanySDirectorAndVpOfTechnologyAndOperationsMember"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_RelatedPartyAdvancesMember" xlink:label="fil_RelatedPartyAdvancesMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_RelatedPartyAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Related party advances </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_RelatedPartyAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Related party advances, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_RelatedPartyAdvancesMember" xlink:to="lab_fil_RelatedPartyAdvancesMember"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_DueToACompanyControlledByTheCooAndAMajorShareholderMember" xlink:label="fil_DueToACompanyControlledByTheCooAndAMajorShareholderMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_DueToACompanyControlledByTheCooAndAMajorShareholderMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Due to a company controlled by the COO and a major shareholder </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_DueToACompanyControlledByTheCooAndAMajorShareholderMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Due to a company controlled by the COO and a major shareholder, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_DueToACompanyControlledByTheCooAndAMajorShareholderMember" xlink:to="lab_fil_DueToACompanyControlledByTheCooAndAMajorShareholderMember"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_DueToVpOfTechnologyAndOperationsMember" xlink:label="fil_DueToVpOfTechnologyAndOperationsMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_DueToVpOfTechnologyAndOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Due to VP of Technology and Operations </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_DueToVpOfTechnologyAndOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Due to VP of Technology and Operations, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_DueToVpOfTechnologyAndOperationsMember" xlink:to="lab_fil_DueToVpOfTechnologyAndOperationsMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Schedule of Deferred Tax Assets and Liabilities </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentAssetsTextBlock" xlink:label="us-gaap_OtherCurrentAssetsTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_OtherCurrentAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Other Current Assets Disclosure </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentAssetsTextBlock" xlink:to="lab_us-gaap_OtherCurrentAssetsTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Organization and Nature of Operations </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Net cash used in investing activities </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US"> Net cash used in investing activities </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Earnings Per Share, Basic </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Gain (loss) on forgiveness of debt </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US"> Gain (loss) on forgiveness of debt </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:to="lab_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Gross margin </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Revenues </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Accumulated deficit </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US"> Accumulated deficit </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> STOCKHOLDERS' DEFICIT </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_NotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Notes and advances payable </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="lab_us-gaap_NotesPayable"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_DueToRelatedPartyCurrent" xlink:label="fil_DueToRelatedPartyCurrent"/>

<link:label xlink:type="resource" xlink:label="lab_fil_DueToRelatedPartyCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Due to related parties - current </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_DueToRelatedPartyCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the monetary amount of Due to related parties - current, as of the indicated date. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_DueToRelatedPartyCurrent" xlink:to="lab_fil_DueToRelatedPartyCurrent"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>

<link:label xlink:type="resource" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Address, Address Line One </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>

<link:label xlink:type="resource" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Document Transition Report </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_NetOperatingLossesWhichMayBeCarriedForwardForeign" xlink:label="fil_NetOperatingLossesWhichMayBeCarriedForwardForeign"/>

<link:label xlink:type="resource" xlink:label="lab_fil_NetOperatingLossesWhichMayBeCarriedForwardForeign" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Net operating losses which may be carried forward - Foreign </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_NetOperatingLossesWhichMayBeCarriedForwardForeign" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the monetary amount of Net operating losses which may be carried forward - Foreign, as of the indicated date. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_NetOperatingLossesWhichMayBeCarriedForwardForeign" xlink:to="lab_fil_NetOperatingLossesWhichMayBeCarriedForwardForeign"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Options oustanding and excersiable </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_DueToACompanyControlledByOurCooMember" xlink:label="fil_DueToACompanyControlledByOurCooMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_DueToACompanyControlledByOurCooMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Due to a company controlled by our COO </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_DueToACompanyControlledByOurCooMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Due to a company controlled by our COO, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_DueToACompanyControlledByOurCooMember" xlink:to="lab_fil_DueToACompanyControlledByOurCooMember"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_SharePurchaseOptionMember" xlink:label="fil_SharePurchaseOptionMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_SharePurchaseOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Share purchase option </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_SharePurchaseOptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Share purchase option, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_SharePurchaseOptionMember" xlink:to="lab_fil_SharePurchaseOptionMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Schedule of Effective Income Tax Rate Reconciliation </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TableTextBlockSupplementAbstract" xlink:label="us-gaap_TableTextBlockSupplementAbstract"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_TableTextBlockSupplementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Tables/Schedules </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TableTextBlockSupplementAbstract" xlink:to="lab_us-gaap_TableTextBlockSupplementAbstract"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Adjustments to reconcile net loss to net cash used in operating activities </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Shares issued on exercise of warrants and options, shares </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_Reserves1Member" xlink:label="fil_Reserves1Member"/>

<link:label xlink:type="resource" xlink:label="lab_fil_Reserves1Member" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Reserves {1} </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_Reserves1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US"> Reserves </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_Reserves1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Reserves, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_Reserves1Member" xlink:to="lab_fil_Reserves1Member"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Weighted Average Number of Shares Outstanding, Basic </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Foreign currency translation Income (loss) </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US"> Foreign currency translation Income (loss) </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Income Statement Location </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Total liabilities </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US"> Total liabilities </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Number of warrants outstanding </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_StockIssuedForCashJuly302020Member" xlink:label="fil_StockIssuedForCashJuly302020Member"/>

<link:label xlink:type="resource" xlink:label="lab_fil_StockIssuedForCashJuly302020Member" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Stock issued for cash, July 30, 2020 </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_StockIssuedForCashJuly302020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Stock issued for cash, July 30, 2020, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_StockIssuedForCashJuly302020Member" xlink:to="lab_fil_StockIssuedForCashJuly302020Member"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:label="us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Deferred Bonus and Profit Sharing Arrangement, Individual Contract, Type of Deferred Compensation </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:to="lab_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_NotesAndAdvancesNotRelatedMember" xlink:label="fil_NotesAndAdvancesNotRelatedMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_NotesAndAdvancesNotRelatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Notes and advances, not related </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_NotesAndAdvancesNotRelatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Notes and advances, not related, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_NotesAndAdvancesNotRelatedMember" xlink:to="lab_fil_NotesAndAdvancesNotRelatedMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Amortization {1} </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US"> Amortization </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_RoyaltyIncurredToACompanyControlledByTheCooAndAMajorShareholderMember" xlink:label="fil_RoyaltyIncurredToACompanyControlledByTheCooAndAMajorShareholderMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_RoyaltyIncurredToACompanyControlledByTheCooAndAMajorShareholderMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Royalty incurred to a company controlled by the COO and a major shareholder </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_RoyaltyIncurredToACompanyControlledByTheCooAndAMajorShareholderMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Royalty incurred to a company controlled by the COO and a major shareholder, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_RoyaltyIncurredToACompanyControlledByTheCooAndAMajorShareholderMember" xlink:to="lab_fil_RoyaltyIncurredToACompanyControlledByTheCooAndAMajorShareholderMember"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20220531.xsd#fil_SharePurchaseWarrantMember" xlink:label="fil_SharePurchaseWarrantMember"/>

<link:label xlink:type="resource" xlink:label="lab_fil_SharePurchaseWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Share purchase warrant </link:label>

<link:label xlink:type="resource" xlink:label="lab_fil_SharePurchaseWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Share purchase warrant, during the indicated time period. </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_SharePurchaseWarrantMember" xlink:to="lab_fil_SharePurchaseWarrantMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Schedule of Amounts Due to Related Parties </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Foreign Currency Translations and Transactions, Policy </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Subsequent Events Disclosure </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Notes and Advances Payable Disclosure </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Stock issued for cash, shares </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Additional Paid-in Capital </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Net income (loss) </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US"> Net income (loss) for the period </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Total operating expenses </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Research and development costs </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> General and administrative expenses </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> CONSOLIDATED BALANCE SHEETS </link:label>

<link:label xlink:type="resource" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US"> CONSOLIDATED BALANCE SHEETS - Parenthetical </link:label>

<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract"/>

</link:labelLink>

</link:linkbase>

7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/15/24  Cell MedX Corp.                   10-Q        2/29/24   53:2.7M                                   Empire Stock Transf… Inc
 1/16/24  Cell MedX Corp.                   10-Q       11/30/23   46:2.3M                                   Empire Stock Transf… Inc
10/16/23  Cell MedX Corp.                   10-Q        8/31/23   42:1.9M                                   Empire Stock Transf… Inc
 9/01/23  Cell MedX Corp.                   10-K        5/31/23   73:3.2M                                   Empire Stock Transf… Inc
 6/29/23  Cell MedX Corp.                   10-Q        2/28/23   53:2.5M                                   Empire Stock Transf… Inc
 5/19/23  Cell MedX Corp.                   10-Q       11/30/22   53:2.4M                                   Empire Stock Transf… Inc
 4/19/23  Cell MedX Corp.                   10-Q        8/31/22   51:2.2M                                   Empire Stock Transf… Inc

22 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/18/22  Cell MedX Corp.                   8-K:1,7,8,910/11/22   17:284K                                   Empire Stock Transf… Inc
 4/11/22  Cell MedX Corp.                   10-Q        2/28/22   56:2.5M                                   Empire Stock Transf… Inc
 1/12/22  Cell MedX Corp.                   10-Q       11/30/21   54:2.4M                                   Empire Stock Transf… Inc
 8/30/21  Cell MedX Corp.                   10-K        5/31/21   83:3.7M                                   Empire Stock Transf… Inc
 5/26/21  Cell MedX Corp.                   8-K:1,3,7,9 5/24/21    4:95K                                    Empire Stock Transf… Inc
 4/09/21  Cell MedX Corp.                   10-Q        2/28/21   56:2.8M                                   Empire Stock Transf… Inc
 1/14/21  Cell MedX Corp.                   10-Q       11/30/20   53:2M                                     Empire Stock Transf… Inc
 9/15/20  Cell MedX Corp.                   10-K        5/31/20   84:2.9M                                   Empire Stock Transf… Inc
 4/14/20  Cell MedX Corp.                   10-Q        2/29/20   67:2.2M                                   Empire Stock Transf… Inc
 1/31/20  Cell MedX Corp.                   8-K:1,9     1/29/20    3:69K                                    Empire Stock Transf… Inc
 1/14/20  Cell MedX Corp.                   10-Q       11/30/19   65:2.2M                                   Empire Stock Transf… Inc
12/31/18  Cell MedX Corp.                   8-K:1,3,9  12/27/18    3:248K                                   Empire Stock Transf… Inc
 9/13/18  Cell MedX Corp.                   10-K        5/31/18   85:3M                                     Empire Stock Transf… Inc
10/17/17  Cell MedX Corp.                   10-Q        8/31/17   59:2.2M                                   Empire Stock Transf… Inc
 8/11/15  Cell MedX Corp.                   8-K:5,9     8/11/15    3:172K                                   Ideal Connection, Inc/FA
11/18/14  Cell MedX Corp.                   8-K:1,9    11/13/14    2:48K                                    Ideal Connection, Inc/FA
11/03/14  Cell MedX Corp.                   8-K:1,9    10/28/14    2:60K                                    Ideal Connection, Inc/FA
10/17/14  Cell MedX Corp.                   8-K:1,9    10/16/14    3:407K                                   Ideal Connection, Inc/FA
10/09/14  Cell MedX Corp.                   10-Q        8/31/14   37:2.9M                                   Ideal Connection, Inc/FA
 8/26/14  Cell MedX Corp.                   10-K        5/31/14   37:1.8M                                   Ideal Connection, Inc/FA
10/13/10  Cell MedX Corp.                   S-1/A                  8:1.2M                                   Toppan Merrill/FA
 7/13/10  Cell MedX Corp.                   S-1                   11:921K                                   Toppan Merrill/FA

↑Top

Filing Submission 0001393905-23-000167 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)